Digital Health & AI Tools in Neuroscience Market - 2026-2033

April 2026 | 67 pages | ID: D7CFABE60D6BEN
DataM Intelligence

Abstracts

Digital Health & AI Tools in Neuroscience Market reached US$ 37.47 billion in 2025 and is expected to reach US$ 79.73 billion by 2033, growing with a CAGR of 9.90% during the forecast period 2026-2033.

The Digital Health & AI Tools in Neuroscience Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Digital Health & AI Tools in Neuroscience Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Component

• Software*
• Hardware
• Services

By Technology

• Machine Learning*
• Signal Processing
• Virtual Reality
• Cloud / Compute & GPU Providers

By Application

• Alzheimer’s / Dementia*
• Stroke & Neurorehabilitation
• Epilepsy / Seizure Monitoring
• Mental Health / Psychiatric Disorders

By End User

• Hospitals*
• Clinics
• Specialty Centers

Regional Analysis for Digital Health & AI Tools in Neuroscience Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Digital Health & AI Tools in Neuroscience Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet byComponent
2.4. Snippet by Technology
2.5. Snippet by Application
2.6. Snippet byEnd User
2.7. Snippet by Region

3. DYNAMICS

3.1. Impacting Factors
  3.1.1. Drivers
    3.1.1.1. Rising Prevalence of Neurological and Psychiatric Disorders Worldwide
    3.1.1.2. Increasing Adoption of AI And Digital Health Platforms
  3.1.2. Restraints
    3.1.2.1. High Cost of Advanced Neuro-AI Tools
    3.1.2.2. Data Privacy, Security and Regulatory Compliance Challenges
  3.1.3. Opportunity
    3.1.3.1. Expansion of Personalized/Precision Digital Therapeutics for Brain Disorders
    3.1.3.2. Growing Collaborations Between Tech Firms and Pharma/Health Systems

4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

4.1. Market Leaders and Pioneers
  4.1.1. Emerging Pioneers and Prominent Players
  4.1.2. Established Leaders with the Largest Marketing Brand
  4.1.3. Market Leaders with Established Products
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
  4.3.1. North America
  4.3.2. Europe
  4.3.3. Asia Pacific
  4.3.4. South America
  4.3.5. Middle East & Africa
4.4. Porter’s Five Forces Analysis
4.5. Patent Analysis
4.6. Unmet Needs and Gaps
4.7. Recommended Strategies for Market Entry and Expansion
4.8. Pricing Analysis and Price Dynamics

5. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY COMPONENT

5.1. Introduction
  5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  5.1.2. Market Attractiveness Index, By Component
5.2. Software*
  5.2.1. Introduction
  5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Hardware
5.4. Services

6. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY TECHNOLOGY

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  6.1.2. Market Attractiveness Index, By Technology
6.2. Machine Learning*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Signal Processing
6.4. Virtual Reality
6.5. Cloud / Compute & GPU Providers

7. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY APPLICATION

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  7.1.2. Market Attractiveness Index, By Application
7.2. Alzheimer’s / Dementia*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Stroke & Neurorehabilitation
7.4. Epilepsy / Seizure Monitoring
7.5. Mental Health / Psychiatric Disorders

8. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY END USER

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinics
8.4. Specialty Centers

9. DIGITAL HEALTH & AI TOOLS IN NEUROSCIENCE MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  9.1.2. Market Attractiveness Index, By Region
9.2. North America
  9.2.1. Introduction
  9.2.2. Key Region-Specific Dynamics
  9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.2.7.1. U.S.
    9.2.7.2. Canada
    9.2.7.3. Mexico
9.3. Europe
  9.3.1. Introduction
  9.3.2. Key Region-Specific Dynamics
  9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.3.7.1. Germany
    9.3.7.2. UK
    9.3.7.3. France
    9.3.7.4. Spain
    9.3.7.5. Italy
    9.3.7.6. Rest of Europe
9.4. Asia-Pacific
  9.4.1. Introduction
  9.4.2. Key Region-Specific Dynamics
  9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.4.7.1. China
    9.4.7.2. India
    9.4.7.3. Japan
    9.4.7.4. South Korea
    9.4.7.5. Rest of Asia-Pacific
9.5. South America
  9.5.1. Introduction
  9.5.2. Key Region-Specific Dynamics
  9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.5.7.1. Brazil
    9.5.7.2. Argentina
    9.5.7.3. Rest of South America
9.6. Middle East and Africa
  9.6.1. Introduction
  9.6.2. Key Region-Specific Dynamics
  9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
  9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

10.1. Competitive Overview and Key Market Players
10.2. Market Share Analysis and Positioning Matrix
10.3. Strategic Partnerships, Mergers & Acquisitions
10.4. Key Developments in Product Portfolios and Innovations
10.5. Company Benchmarking

11. COMPANY PROFILES

11.1. Akili Interactive*
  11.1.1. Company Overview
  11.1.2. Product Portfolio
    11.1.2.1. Product Description
    11.1.2.2. Product Key Performance Indicators (KPIs)
  11.1.3. Financial Overview
    11.1.3.1. Company Revenue
    11.1.3.2. Geographical Revenue Shares
    11.1.3.3. Revenue Forecasts
  11.1.4. Key Developments
    11.1.4.1. Mergers & Acquisitions
    11.1.4.2. Key Product Development Activities
    11.1.4.3. Regulatory Approvals, etc.
  11.1.5. SWOT Analysis
11.2. Pear Therapeutics
11.3. Biofourmis
11.4. Empatica
11.5. Neuroelectrics
11.6. Neuralink
11.7. Blackrock Neurotech
11.8. Synchron
11.9. MindMaze
11.10. Precision Neuroscience ( LIST NOT EXHAUSTIVE )

12. ASSUMPTIONS AND RESEARCH METHODOLOGY

12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation

13. APPENDIX

13.1. About Us and Services
13.2. Contact Us